ALNYLAM, created in 2002 (United States), from 1 sister brand and 2214 competing brands. ALNYLAM is owned by Alnylam Pharmaceuticals Inc, listed on the stock exchange of New York ALNYLAM is part of the Biotechnology activity sector.

ALNYLAM is a brand of Alnylam Pharmaceuticals Inc (ALNY) Share price

International deposit : 2002 Business sector Biotechnology

Share price and profitability of the share Alnylam Pharmaceuticals Inc (ALNYLAM)

Buy Alnylam Pharmaceuticals Inc share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 146.07

Portfolio valuation
Alnylam Pharmaceuticals Inc (ALNYLAM) over 5 years* USD 245.90

Stock market history Alnylam Pharmaceuticals Inc (ALNYLAM)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
Alnylam Pharmaceuticals Inc

See more brands of Alnylam Pharmaceuticals Inc

Rival brands
ALNYLAM

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS